Annual Drug Patent Expirations for MEKTOVI
Mektovi is a drug marketed by Array Biopharma Inc and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
Drug patent litigation for MEKTOVI.
This drug has two hundred and two patent family members in fifty-five countries.
The generic ingredient in MEKTOVI is binimetinib. One supplier is listed for this compound. Additional details are available on the binimetinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
